Integrin ανβ3 is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase β/ζ

FASEB Journal

Volumn 23, Issue 5, 2009, Pages 1459-1469

  Mikelis, Constantinos ^a   Sfaelou, Evanthia ^a   Koutsioumpa, Marina ^a   Kieffer, Nelly ^b   Papadimitriou, Evangelia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Glioma; Heparin affin regulatory peptide; Heparin binding growth associated molecule; Tumor growth

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; MIDKINE; MONOCLONAL ANTIBODY; PLEIOTROPHIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE BETA; PROTEIN TYROSINE PHOSPHATASE ZETA; SYNDECAN 3; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR; CARRIER PROTEIN; CYTOKINE; PROTEIN TYROSINE KINASE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL MEMBRANE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLIOMA CELL; HUMAN; HUMAN CELL; ONCOGENE SRC; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL CULTURE; CELL MOTION; METABOLISM; PHYSIOLOGY;

CARRIER PROTEINS; CELL MOVEMENT; CELLS, CULTURED; CYTOKINES; HUMANS; INTEGRIN ALPHAVBETA3; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; SRC-FAMILY KINASES;

EID: 70349314422     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-117564     Document Type: Article

References (50)

1. Mikelis, C., Koutsioumpa, M., and Papadimitriou, E. (2007) Pleiotrophin as a possible new target for angiogenesis-related diseases and cancer. Recent Patents Anticancer Drug Discov. 2, 175-186 (Pubitemid 46957318)
2. Mikelis, C., and Papadimitriou, E. (2008) Heparin binding protein pleiotrophin: An important player in the angiogenic process. Connect. Tissue Res. 49, 149-152
3. Polykratis, A., Katsoris, P., Courty, J., and Papadimitriou, E. (2005) Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J. Biol. Chem. 280, 22454-22461 (Pubitemid 40827901)
4. Maeda, N., Hamanaka, H., Shintani, T., Nishiwaki, T., and Noda, M. (1994) Multiple receptor-like protein tyrosine phosphatases in the form of chondroitin sulfate proteoglycan. FEBS Lett. 354, 67-70 (Pubitemid 24331707)
5. Fujikawa, A., Shirasaka, D., Yamamoto, S., Ota, H., Yahiro, K., Fukada, M., Shintani, T., Wada, A., Aoyama, N., Hirayama, T., Fukamachi, H., and Noda, M. (2003) Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 33, 375-381 (Pubitemid 36278854)
6. Garwood, J., Heck, N., Reichardt, F., and Faissner, A. (2003) Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth. J. Biol. Chem. 278, 24164-24173 (Pubitemid 36830252)
7. Peles, E., Schlessinger, J., and Grumet, M. (1998) Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling. Trends Biochem. Sci. 23, 121-124 (Pubitemid 28189520)
8. Harroch, S., Furtado, G. C., Brueck, W., Rosenbluth, J., Lafaille, J., Chao, M., Buxbaum, J. D., and Schlessinger, J. (2002) A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat. Genet. 32, 411-414 (Pubitemid 35266117)
9. Fukazawa, N., Yokoyama, S., Eiraku, M., Kengaku, M., and Maeda, N. (2008) Receptor type protein tyrosine phosphatase zeta-pleiotrophin signaling controls endocytic trafficking of DNER that regulates neuritogenesis. Mol. Cell. Biol. 28, 4494-4506 (Pubitemid 351977749)
10. Muramatsu, H., Zou, P., Suzuki, H., Oda, Y., Chen, G. Y., Sakaguchi, N., Sakuma, S., Maeda, N., Noda, M., Takada, Y., and Muramatsu, T. (2004) alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor. J. Cell Sci. 117, 5405-5415
11. Hynes, R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687
12. Hodivala-Dilke, K. M., Reynolds, A. R., and Reynolds, L. E. (2003) Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res. 314, 131-144
13. Stupack, D. G., and Cheresh, D. A. (2004) Integrins and angiogenesis. Curr. Top. Dev. Biol. 64, 207-238
14. Falcioni, R., Antonini, A., Nistico, P., Di Stefano, S., Crescenzi, M., Natali, P. G., and Sacchi, A. (1997) Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp. Cell. Res. 236, 76-85 (Pubitemid 27452351)
15. Borges, E., Jan, Y., and Ruoslahti, E. (2000) Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J. Biol. Chem. 275, 39867-39873 (Pubitemid 32064606)
16. Patsenker, E., Popov, Y., Wiesner, M., Goodman, S. L., and Schuppan, D. (2007) Pharmacological inhibition of the vitro-nectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J. Hepatol. 46, 878-887 (Pubitemid 46529034)
17. Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F., and Byzova, T. V. (2007) Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ. Res. 101, 570-580 (Pubitemid 351325874)
18. Von Wichert, G., Jiang, G., Kostic, A., De Vos, K., Sap, J., and Sheetz, M. P. (2003) RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin-cytoskeleton linkages. J. Cell Biol. 161, 143-153
19. Vulin, A. I., Jacob, K. K., and Stanley, F. M. (2005) Integrin activates receptor-like protein tyrosine phosphatase alpha, Src, and Rho to increase prolactin gene expression through a final phosphatidylinositol 3-kinase/cytoskeletal pathway that is additive with insulin. Endocrinology 146, 3535-3546
20. Schaffner-Reckinger, E., Gouon, V., Melchior, C., Plancon, S., and Kieffer, N. (1998) Distinct involvement of β3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signaling. J. Biol. Chem. 273, 12623-12632 (Pubitemid 28240640)
21. Parthymou, A., Kardamakis, D., Pavlopoulos, I., and Papadimitriou, E. (2004) Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro. Int. J. Cancer 110, 807-814 (Pubitemid 38758505)
22. Huang, Y., Shi, H., Zhou, H., Song, X., Yuan, S., and Luo, Y. (2006) The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107, 3564-3571
23. Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571
24. Maile, L. A., Busby, W. H., Sitko, K., Capps, B. E., Sergent, T., Badley-Clarke, J., and Clemmons, D. R. (2006) Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Mol. Endocrinol. 20, 405-413 (Pubitemid 43152513)
25. Takagi, J., Kamata, T., Meredith, J., Puzon-McLaughlin, W., and Takada, Y. (1997) Changing ligand specificities of alphavbeta1 and alphavbeta3 integrins by swapping a short diverse sequence of the beta subunit. J. Biol. Chem. 272, 19794-19800 (Pubitemid 27340072)
26. Switala-Jelen, K., Dabrowska, K., Opolski, A., Lipinska, L., Nowaczyk, M., and Gorski, A. (2004) The biological functions of β3 integrins. Folia Biol. (Praha) 50, 143-152
27. 3 integrin deficiency promotes cardiac hypertrophy and inflammation. J. Mol. Cell. Cardiol. 42, 367-377
28. Wang, D., Oparil, S., Feng, J. A., Li, P., Perry, G., Chen, L. B., Dai, M., John, S. W., and Chen, Y. F. (2003) Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 42, 88-95 (Pubitemid 36842241)
29. Sato, Y., Takita, H., Ohata, N., Tamura, M., and Kuboki, Y. (2002) Pleiotrophin regulates bone morphogenetic protein (BMP)-induced ectopic osteogenesis. J. Biochem. 131, 877-886 (Pubitemid 34717593)
30. 3-integrin and bone sialoprotein during cultured osteoblast differentiation. Bone 24, 321-327
31. Schmitz, M., Grignard, G., Margue, C., Dippel, W., Capesius, C., Mossong, J., Nathan, M., Giacchi, S., Scheiden, R., and Kieffer, N. (2007) Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis. Int. J. Cancer 120, 1284-1292 (Pubitemid 46256782)
32. Li, G., Hu, Y., Huo, Y., Liu, M., Freeman, D., Gao, J., Liu, X., Wu, D. C., and Wu, H. (2006) PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. J. Biol. Chem. 281, 10663-10668 (Pubitemid 43855487)
33. Arias-Salgado, E. G., Lizano, S., Sarkar, S., Brugge, J. S., Ginsberg, M. H., and Shattil, S. J. (2003) Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc. Natl. Acad. Sci. U. S. A. 100, 13298-13302 (Pubitemid 37444736)
34. Shattil, S. J. (2005) Integrins and Src: dynamic duo of adhesion signaling. Trends Cell Biol. 15, 399-403 (Pubitemid 41125771)
35. Lorente, G., Nelson, A., Mueller, S., Kuo, J., Urfer, R., Nikolich, K., and Foehr, E. D. (2005) Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment. Neuro. Oncol. 7, 154-163 (Pubitemid 40590515)
36. Chow, J. P., Fujikawa, A., Shimizu, H., Suzuki, R., and Noda, M. (2008) Metalloproteinase- and γ-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. J. Biol. Chem. 283, 30879-30889
37. Arias-Salgado, E. G., Haj, F., Dubois, C., Moran, B., Kasirer-Friede, A., Furie, B. C., Furie, B., Neel, B. G., and Shattil, S. J. (2005) PTP-1B is an essential positive regulator of platelet integrin signaling. J. Cell Biol. 170, 837-845 (Pubitemid 41242115)
38. Mahabeleshwar, G. H., Chen, J., Feng, W., Somanath, P. R., Razorenova, O. V., and Byzova, T. V. (2008) Integrin affinity modulation in angiogenesis. Cell Cycle 7, 335-347
39. Polytarchou, C., Hatziapostolou, M., and Papadimitriou, E. (2005) Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 280, 40428-40435 (Pubitemid 41780529)
40. Hatziapostolou, M., Polytarchou, C., Katsoris, P., Courty, J., and Papadimitriou, E. (2006) Heparin affin regulatory peptide/pleiotrophin regulates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells. J. Biol. Chem. 281, 32217-32226 (Pubitemid 46036776)
41. Polytarchou, C., Hatziapostolou, M., Poimenidi, E., Mikelis, C., Papadopoulou, A., Parthymou, A., and Papadimitriou, E. (2009) Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase β/ζ. [E-pub ahead of print] Int. J. Cancer doi: 10.1002/ijc.24084
42. Koutsioumpa, M., Hatziapostolou, M., Mikelis, C., Koolwijk, P., and Papadimitriou, E. (2009) Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase β/ζ. Eur. J. Pharmacol. 602, 245-249
43. Heroult, M., Bernard-Pierrot, I., Delbe, J., Hamma-Kourbali, Y., Katsoris, P., Barritault, D., Papadimitriou, E., Plouet, J., and Courty, J. (2004) Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23, 1745-1753 (Pubitemid 38445166)
44. Yuki, T., Ishihara, S., Rumi, M. A., Ortega-Cava, C. F., Kadowaki, Y., Kazumori, H., Ishimura, N., Amano, Y., Moriyama, N., and Kinoshita, Y. (2006) Increased expression of midkine in the rat colon during healing of experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G735-G743 (Pubitemid 44511691)
45. Chen, H., Gordon, M. S., Campbell, R. A., Li, M., Wang, C. S., Lee, H. J., Sanchez, E., Manyak, S. J., Gui, D., Shalitin, D., Said, J., Chang, Y., Deuel, T. F., Baritaki, S., Bonavida, D., and Berenson, J. R. (2007) Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth. Blood 110, 287-295 (Pubitemid 47026846)
46. Ezquerra, L., Alguacil, L. F., Nguyen, T., Deuel, T. F., Silos-Santiago, I., and Herradon, G. (2008) Different pattern of pleiotrophin and midkine expression in neuropathic pain: correlation between changes in pleiotrophin gene expression and rat strain differences in neuropathic pain. Growth Factors 26, 44-48
47. Parthymou, A., Lampropoulou, E., Mikelis, C., Drosou, G., and Papadimitriou, E. (2008) Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells. Eur. J. Cell Biol. 87, 17-29 (Pubitemid 350246273)
48. Schnell, O., Krebs, B., Wagner, E., Romagna, A., Beer, A. J., Grau, S. J., Thon, N., Goetz, C., Kretzschmar, H. A., Tonn, J. C., and Goldbrunner, R. H. (2008) Expression of Integrin alpha(v) beta(3) in gliomas correlates with tumor grade and is not restricted to tumor vasculature. Brain Pathol. 18, 378-386 (Pubitemid 351782847)
49. Reardon, D. A., Rich, J. N., Friedman, H. S., and Bigner, D. D. (2006) Recent advances in the treatment of malignant astrocytoma. J. Clin. Oncol. 24, 1253-1265 (Pubitemid 46622028)
50. Chen, Y. Q., Trikha, M., Gao, X., Bazaz, R., Porter, A. T., Timar, J., and Honn, K. V. (1997) Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin. Int. J. Cancer 72, 642-648 (Pubitemid 27356167)